Mesothelioma News Headlines

Data from clinical trials indicate that peritoneal mesothelioma, a cancer that develops in the lining of the abdomen, can occur even at low levels of exposure to asbestos.

Extrapleural pneumonectomy (EPP) and pleurectomy/decortication (P/D) are the two main surgical options for treating malignant pleural mesothelioma.

A recent study from Queen Mary's Hospital recommends adding omental mesothelioma, a rare form of peritoneal mesothelioma, as part of making a differential diagnosis.

The National Cancer Institute is conducting a clinical trial to investigate the effectiveness of MORAb-009 in the treatment of malignant pleural mesothelioma.

Lung cancer is the leading cause of cancer related deaths, with mesothelioma, a malignancy due to asbestos, being one form of non small cell lung cancer.

ATRA, an all-trans-retonic acid, is being studied as a viable option for helping treat mesothelioma as an inhibitor of tumor growth and slowing the progression of the disease.

Results from a recent study have shown promising results with the use of a novel agent, FUS1/TUSC2 in targeting molecular pathways to inhibit the proliferation and survival of tumor cells and is worthy of further investigation as an effective mesothelioma treatment option.

Bionomics is beginning a Phase II Clinical Trial investigating a new anti-cancer drug, BNC105, and its effectiveness at stopping the progression or even curing mesothelioma.

Mesothelioma Patients diagnosed with Stage IV cancer often have less than a year to live. Despite being difficult, having conversations about end of life care can be hugely beneficial to patients and family members.

Two medical research institutes, Wake Forest Baptist Medical Center and FirstHealth Moore Regional Hospital, in North Carolina have partnered to investigate the factors leading to mesothelioma in hopes of more effectively identifying patients who are at high risk of developing the deadly disease.

There are certain steps that one can take upon receiving the devasting news of being diagnosed with malignant mesothelioma. This article shares helpful information for patients and loved ones during such difficult times when one is first diagnosed.

When given a diagnosis of mesothelioma, there are certain steps one can take that will make the process of coping with a terminal illness easier and ensure that medical costs get covered by insurance and/or by a successful asbestos lawsuit.

Being diagnosed with a terminal cancer such as mesothelioma is devasting and overwhelming. It requires great courage and support to enter into end of life conversations, and yet can be one of the most helpful things to do to ensure more choice, power and dignity about how and where one would like to spend their final months.

A Phase I Clinical Trial studying a new treatment option for patients with unresectable pleural mesothelioma holds promise to extend survival times and improve quality of life.

Mesothelioma is a serious, often fatal disease caused by exposure to asbestos. Getting quality end of life care is essential to ensuring the mesothelioma patient's wishes are followed and sensitivity is given to friends and family members.

For the first time, the FDA has approved a drug to be used as maintenance therapy for patients who have non-small cell lung cancer, including mesothelioma. Studies reveal such treatment can extend a mesothelioma patient’s survival time by three months.

Mesothelioma is an incurable form of cancer that is often diagnosed in the late stages. Palliative and end of life care is essential to any treatment plan. Quality end of life care ensures a patient's wishes are followed and the best quality of life during such a difficult time.

Improving quality of life through good palliative care and pain management is essential for patients suffering from malignant mesothelioma.

Mesothelioma is an incurable cancer caused by exposure to asbestos. Symptoms of the disease do not surface until decades after exposure. Therefore, mesothelioma is usually not diagnosed until it has advanced to late stages. Comprehensive, empathic end-of-life care for patients with mesothelioma is critical for ensuring the best quality of life possible.

Mesothelioma patients who do not respond to standard forms of pain therapy may benefit from a new medical device offered by Competitive Technologies that biophysically relieves pain without harmful side effects associated with pharmaceuticals.

Treatment of mesothelioma, a rare form of cancer caused by exposure to asbestos, often includes some form of chemotherapy. Many patients who receive chemotherapy also experience severe stomach upset and nausea. A recent study finds that taking ginger supplements before and after such treatments can greatly reduce these symptooms.

Mesothelioma is a rare form of cancer caused primarily by exposure to asbestos. Along with standard therapies, such as surgery, chemotherapy and radiation, there are many complementary and alternative treatments that can be integrated with conventional ones to improve overall quality of life.

Addressing psychological, social and spiritual factors as part of palliative care and pain management is a crucial, important component of treatment for patients diagnosed with mesothelioma.

Mesothelioma is a rare cancer primarily caused by exposure to asbestos. Often diagnosed in late stages of the disease, pain management and palliative care are central to any treatment plans. Patients often benefit from integrating nonpharmacological treatments (without the use of drugs or medications) with pharmacological ones to get the most pain relief and increased quality of life.

Most patients diagnosed with cancer experience pain, and even more so for mesothelioma patients because it is often not diagnosed until the cancer is advanced Pain management and palliative care is vital.

Malignant pleural mesothelioma is an aggressive tumor caused primarily by asbestos exposure that usually has a poor prognosis. Combination regimens used in chemotherapy are often first line therapy options for patients with MPM. Standard care has included a combination of cisplatin with pemetrexed, however with significant side effects. An alternative combination of carboplatin with pemetrexed shows promise of yielding similar results yet with less toxicity, thereby reducing negative side effects.

Cancer researchers recently discussed a novel therapy aimed at helping treat and cure cancers, such as mesothelioma, at the American Association for Cancer Research meeting. The aim is to target cancer stem cells themselves versus just cancer cells, reducing the ability for cancers to recur and metastasize.

Looking at the epidemiology of mesothelioma and the role asbestos plays in causing the disease is the first step in understanding and intervening to decrease risk and increase chances of survival.

Mesothelioma is a rare, often fatal disease primarily caused by exposure to asbestos. Standard treatment options for treating cancer, such as surgery, chemotherapy and radiation, have not been very effective. Now a new combination drug therapy shows promise of being an effective treatment and increasing survival time and quality of life.

As part of our ongoing series on mesothelioma treatments, this article explores an experimental mode of treating malignant mesothelioma called gene therapy, also referred to as molecular or biological therapy.